XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Feb. 05, 2022
Jan. 30, 2021
Cash flows from operating activities:    
Net income $ 1,157,034 $ 1,065,765
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 43,227 56,943
Undistributed earnings in joint venture—Majestic 21 (12,557) (13,708)
Decrease (Increase) in fair market value of equity investments 4,093 (79,956)
Stock-based compensation 35,353 20,521
Amortization of operating lease right of use assets 1,597 10,331
Decrease (increase) in:    
Accounts receivable - trade 186,724 (267,040)
Pre-owned homes 314,979 (216,973)
Inventories (508,290) (1,309,716)
Prepaid expenses and other current assets 202,697 (538,208)
Interest receivable   (8,444)
Income taxes receivable   105,676
(Decrease) increase in:    
Accounts payable 58,905 172,260
Accrued compensation 37,776 (223,775)
Accrued expenses and other current liabilities (88,108) (270,148)
Income taxes payable 369,396 230,133
Customer deposits (877,796) 2,701,182
Net cash provided by operating activities 925,030 1,434,843
Cash flows from investing activities:    
Purchase of property, plant and equipment (118,783) (278,070)
Proceeds from certificates of deposit 2,087,936 1,500,000
Collections on interest receivable 5,079 28,640
Collections on mortgage notes receivable 627 609
Issuance of mobile home park not receivable (63,778)  
Collections on equipment and other notes receivable 14,443 6,738
Increase in cash surrender value of life insurance (42,759) (44,550)
Net cash provided by investing activities 1,882,765 1,213,367
Cash flows from financing activities:    
Proceeds from exercise of employee stock options   15,125
Reduction of operating lease obligation (1,597) (5,714)
Net cash (used in) provided by financing activities (1,597) 9,411
Increase cash and cash equivalents 2,806,198 2,657,621
Cash and cash equivalents at beginning of year 36,126,059 30,305,902
Cash and cash equivalents at end of quarter 38,932,257 $ 32,963,523
Supplemental financing activity:    
Noncash exercise of employee stock options $ (9,197)